The United States has authorized for the first time a vaccine designed to protect babies against bronchiolitis, to be administered to pregnant women, the country’s health authorities announced Monday.
The vaccine will be marketed by pharmaceutical giant Pfizer under the name Abrysvo and targets respiratory syncytial virus (RSV), which particularly affects young children.
The single intramuscular injection vaccine has been licensed for pregnant women between 32 and 36 weeks of gestation, the US Food and Drug Administration (FDA) said.
Children, according to the FDA, will be protected from RSV for the first six months of life.
The same vaccine has already been approved in the US for people 60 years of age or older and in July it was also approved by the European Medicines Agency (EMA), but the European Commission will still have to decide whether to authorize its introduction into the European market. .
Source: TSF
